Alcyone Therapeutics
Edgar D. Jannotta, Jr. is on the Board of Directors at Alcyone Therapeutics. Edgar is also the Former Managing Principle and Co-Manager of Healthcare Group at GTCR GOLDER RAUNER, LLC.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Alcyone Therapeutics
Alcyone Therapeutics is a biotechnology company pioneering next-generation precision central nervous system (CNS) therapies to improve the lives of patients and families impacted by severe neurological conditions. Alcyone Therapeutics is advancing a pipeline of adeno-associated virus (AAV) gene therapy programs that leverage its proprietary, next-generation CNS delivery technology platform. Alcyone Therapeutics’ lead programs target the treatment of Rett syndrome and spinal muscular atrophy with respiratory distress type 1 (SMARD1).